Dr Malcolm Ball

Gratuk Technologies and MediKane Holdings

Dr Malcolm Ball is CEO & Founder of Gratuk Technologies Pty Ltd and Director, Chief Scientific Officer and Founder of MediKane Holdings Ltd.

Malcolm was granted a PhD from the UNSW Co-operative Research Centre for Eye Research and Technology in the development of novel methods for the purification and chemical characterisation of high molecular weight glycoproteins. Malcolm started his career in medical devices and pharmaceuticals primarily in the field of glycoprotein purification, analysis and biosynthesis, during that time he led teams in product design for small and large molecules. He has also consulted on many projects for entities such as CibaVision, Johnson & Johnson, Medical Therapeutics Pty Ltd and Novotech Pty Ltd.

In 2009, Malcolm founded Gratuk Technologies with his Partner and in 2011 they moved into the medical food space founding MediKane to take products to market. Malcolm has designed and obtained regulatory approval for 41 products in the food, medical device, bioanalytical and pharma sectors, and has had a long successful research relationship with Macquarie University being an industry partner for many successful grants.

Back Now